entity

amyloid_plaque

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about amyloid_plaque: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

5Connections

2Hypotheses

4Analyses

3Outgoing

2Incoming

10Experiments

4Debates

No AI portrait yet

Outgoing (3)

Target	Relation	Type	Str
ds-b3d65f2c2ca6	provides_data_for	dataset	1.00
ds-6784494f1741	provides_data_for	dataset	1.00
ds-6784494f1741	data_in	dataset	1.00

Incoming (2)

Source	Relation	Type	Str
ds-b3d65f2c2ca6	data_in	dataset	1.00
ds-6784494f1741	data_in	dataset	1.00

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
TREM2-Deficient Microglia as Drivers of Amyloid Plaque Toxic	0.827	neurodegeneration	Legacy Pre-Pipeline Hypothesis Import
Amyloid Plaque Clearance Triggers Downstream Reduction in Ta	0.475	-	Can CSF p-tau217 normalization serve as

Mentioning Analyses (4)

Scientific analyses that reference this entity

Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other

neurodegeneration | 2026-04-25 | 8 hypotheses Top: 0.640

What signals trigger microglia to specifically recognize and phagocytose LC axon

neuroinflammation | 2026-04-14 | 0 hypotheses

Why does the V1613M variant reduce amyloid pathology when ABCA7 loss-of-function

neurodegeneration | 2026-04-14 | 2 hypotheses Top: 0.619

What evidence supports Cdk5 activation as THE primary cause of AD versus other e

neurodegeneration | 2026-04-10 | 0 hypotheses

Experiments (10)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Model	Status	Est. Cost
Single nuclei transcriptomic and epigenomic profiling of 84 donors acr	gene_expression	Alzheimer's disease	0.500	human	extracted	N/A
The Seattle Alzheimer's Disease Brain Cell Atlas (SEA-AD) integrates n	neuropathology	Alzheimer's disease	0.500	human	extracted	N/A
In late life, NfL demonstrated the strongest association with incident	clinical	Alzheimer's disease	0.500	human	extracted	N/A
Complex gene expression differences were identified, ranging from glob	gene_expression	Alzheimer's disease	0.500	post_mortem_brain	extracted	N/A
A subset of donors with particularly severe cellular and molecular phe	clinical	Alzheimer's disease	0.500	human	extracted	N/A
Midlife hypertension was associated with 0.15-SD faster NfL increase a	clinical	Alzheimer's disease	0.500	human	extracted	N/A
A subset of donors exhibited particularly severe cellular and molecula	computational	Alzheimer's disease	0.500	human	extracted	N/A
Cell type-specific analysis identified early-phase loss of somatostati	gene_expression	Alzheimer's disease	0.500	human	extracted	N/A
Single-cell/multiomics analysis of 84 human post-mortem brains reveale	computational	Alzheimer's disease	0.500	human	extracted	N/A
Temporal analysis of gene expression differences across disease progre	gene_expression	Alzheimer's disease	0.500	human	extracted	N/A

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (4)

Multi-agent debates referencing this entity

Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other

closed · Rounds: 4 · Score: 0.66 · 2026-04-25

The abstract claims Cdk5 activation is the primary cause of AD, contradicting th

closed · Rounds: 4 · Score: 0.50 · 2026-04-20

The study shows that OB microglia phagocytose LC axons before amyloid plaque for

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

The abstract shows V1613M variant reduces amyloid plaques and damage in 5xFAD mi

closed · Rounds: 4 · Score: 0.60 · 2026-04-15

Related Research

Hypotheses and analyses mentioning amyloid_plaque in their description or question text

No additional research found